191 related articles for article (PubMed ID: 24681953)
1. Persistent STAT5 activation in myeloid neoplasms recruits p53 into gene regulation.
Girardot M; Pecquet C; Chachoua I; Van Hees J; Guibert S; Ferrant A; Knoops L; Baxter EJ; Beer PA; Giraudier S; Moriggl R; Vainchenker W; Green AR; Constantinescu SN
Oncogene; 2015 Mar; 34(10):1323-32. PubMed ID: 24681953
[TBL] [Abstract][Full Text] [Related]
2. Signal transducer and activator of transcription STAT5 is recruited to c-Myc super-enhancer.
Pinz S; Unser S; Rascle A
BMC Mol Biol; 2016 Apr; 17():10. PubMed ID: 27074708
[TBL] [Abstract][Full Text] [Related]
3. Differential binding activity of the transcription factor LIL-STAT in immature and differentiated normal and leukemic myeloid cells.
Tuyt LM; Bregman K; Lummen C; Dokter WH; Vellenga E
Blood; 1998 Aug; 92(4):1364-73. PubMed ID: 9694725
[TBL] [Abstract][Full Text] [Related]
4. Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines.
Weber-Nordt RM; Egen C; Wehinger J; Ludwig W; Gouilleux-Gruart V; Mertelsmann R; Finke J
Blood; 1996 Aug; 88(3):809-16. PubMed ID: 8704235
[TBL] [Abstract][Full Text] [Related]
5. FYN expression potentiates FLT3-ITD induced STAT5 signaling in acute myeloid leukemia.
Chougule RA; Kazi JU; Rönnstrand L
Oncotarget; 2016 Mar; 7(9):9964-74. PubMed ID: 26848862
[TBL] [Abstract][Full Text] [Related]
6. p53 suppresses cytokine induced, Stat5 mediated activation of transcription.
Fritsche M; Mundt M; Merkle C; Jähne R; Groner B
Mol Cell Endocrinol; 1998 Aug; 143(1-2):143-54. PubMed ID: 9806359
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the interferon regulatory factor-8 (IRF-8) tumor suppressor gene by the signal transducer and activator of transcription 5 (STAT5) transcription factor in chronic myeloid leukemia.
Waight JD; Banik D; Griffiths EA; Nemeth MJ; Abrams SI
J Biol Chem; 2014 May; 289(22):15642-52. PubMed ID: 24753251
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone regulation of insulin-like growth factor-I gene expression may be mediated by multiple distal signal transducer and activator of transcription 5 binding sites.
Eleswarapu S; Gu Z; Jiang H
Endocrinology; 2008 May; 149(5):2230-40. PubMed ID: 18276757
[TBL] [Abstract][Full Text] [Related]
9. Identification of a STAT5 target gene, Dpf3, provides novel insights in chronic lymphocytic leukemia.
Theodorou M; Speletas M; Mamara A; Papachristopoulou G; Lazou V; Scorilas A; Katsantoni E
PLoS One; 2013; 8(10):e76155. PubMed ID: 24155890
[TBL] [Abstract][Full Text] [Related]
10. Constitutive STAT5 activation specifically cooperates with the loss of p53 function in B-cell lymphomagenesis.
Joliot V; Cormier F; Medyouf H; Alcalde H; Ghysdael J
Oncogene; 2006 Aug; 25(33):4573-84. PubMed ID: 16532027
[TBL] [Abstract][Full Text] [Related]
11. Nuclear localization of pyruvate dehydrogenase complex-E2 (PDC-E2), a mitochondrial enzyme, and its role in signal transducer and activator of transcription 5 (STAT5)-dependent gene transcription.
Chueh FY; Leong KF; Cronk RJ; Venkitachalam S; Pabich S; Yu CL
Cell Signal; 2011 Jul; 23(7):1170-8. PubMed ID: 21397011
[TBL] [Abstract][Full Text] [Related]
12. The natural chemopreventive agent sulforaphane inhibits STAT5 activity.
Pinz S; Unser S; Rascle A
PLoS One; 2014; 9(6):e99391. PubMed ID: 24910998
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of genome-wide chromatin library of Stat5 binding sites in human breast cancer.
LeBaron MJ; Xie J; Rui H
Mol Cancer; 2005 Feb; 4(1):6. PubMed ID: 15686596
[TBL] [Abstract][Full Text] [Related]
14. Persistent STAT5-mediated ROS production and involvement of aberrant p53 apoptotic signaling in the resistance of chronic myeloid leukemia to imatinib.
Cheng Y; Hao Y; Zhang A; Hu C; Jiang X; Wu Q; Xu X
Int J Mol Med; 2018 Jan; 41(1):455-463. PubMed ID: 29115375
[TBL] [Abstract][Full Text] [Related]
15. Differential STAT5 signaling by ligand-dependent and constitutively active cytokine receptors.
Moucadel V; Constantinescu SN
J Biol Chem; 2005 Apr; 280(14):13364-73. PubMed ID: 15677477
[TBL] [Abstract][Full Text] [Related]
16. Amifostine impairs p53-mediated apoptosis of human myeloid leukemia cells.
Acosta JC; Richard C; Delgado MD; Horita M; Rizzo MG; Fernández-Luna JL; León J
Mol Cancer Ther; 2003 Sep; 2(9):893-900. PubMed ID: 14555708
[TBL] [Abstract][Full Text] [Related]
17. Constitutive activation of the JAK2/STAT5 signal transduction pathway correlates with growth factor independence of megakaryocytic leukemic cell lines.
Liu RY; Fan C; Garcia R; Jove R; Zuckerman KS
Blood; 1999 Apr; 93(7):2369-79. PubMed ID: 10090948
[TBL] [Abstract][Full Text] [Related]
18. FRA2 is a STAT5 target gene regulated by IL-2 in human CD4 T cells.
Rani A; Greenlaw R; Runglall M; Jurcevic S; John S
PLoS One; 2014; 9(2):e90370. PubMed ID: 24587342
[TBL] [Abstract][Full Text] [Related]
19. The dual role of LSD1 and HDAC3 in STAT5-dependent transcription is determined by protein interactions, binding affinities, motifs and genomic positions.
Nanou A; Toumpeki C; Lavigne MD; Lazou V; Demmers J; Paparountas T; Thanos D; Katsantoni E
Nucleic Acids Res; 2017 Jan; 45(1):142-154. PubMed ID: 27651463
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial translocation of signal transducer and activator of transcription 5 (STAT5) in leukemic T cells and cytokine-stimulated cells.
Chueh FY; Leong KF; Yu CL
Biochem Biophys Res Commun; 2010 Nov; 402(4):778-83. PubMed ID: 21036145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
